Inflammation, angiogenesis, and coagulation are linked to the development of cancer. In
glioblastoma, microvascular proliferation is a hallmark, and lymphocytic infiltration is a common …

Background We conducted a multicenter, 2-stage, open-label, phase II trial to assess the
efficacy and safety of dacomitinib in adult patients with recurrent glioblastoma (GB) and …

Purpose: The DNA repair enzyme O 6 -methylguanine DNA methyltransferase (MGMT)
inhibits the killing of tumor cells by alkylating agents, and its loss in cancer cells is associated …

Background Circulating endothelial cells and microparticles have prognostic value in cancer,
and might be predictors of response to chemotherapy and antiangiogenic treatments. We …

Diffuse infiltrating low-grade gliomas include oligodendrogliomas and astrocytomas, and
account for about 5% of all primary brain tumors. Treatment strategies for these low-grade …

Background Glioblastoma (GBM) is the most aggressive primary brain tumor, characterized
by a heterogeneous and abnormal vascularity. Subtypes of vascular habitats within the …

There is no ‘standard of care’for recurrent malignant glioma (MG). Our aim is to confirm the
efficacy and safety of bevacizumab 10 mg/kg plus irinotecan 125 mg/m 2 (or 340 mg/m 2 if …

We sought to determine the impact of bevacizumab on reduction of tumor size prior to
chemoradiotherapy in unresected glioblastoma patients. Patients were randomized 1:1 to receive …

Background The microvessels area (MVA), derived from microvascular proliferation, is a
biomarker useful for high-grade glioma classification. Nevertheless, its measurement is costly, …

Aim Circulating endothelial cells and microparticles are prognostic factors in cancer.
However, their prognostic and predictive value in patients with glioblastoma is unclear. The …